CytoTronics

CytoTronics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.cytotronics.com

Last Round

Seed

Sep 5, 2024

Total Funding Raised

$22.75M

Momentum Score

25 /100

Company Overview

CytoTronics is a biotechnology company that develops semiconductor-based systems for studying cell biology, enabling researchers to visualize live cell function at scale and obtain real-time data on cell behavior to explore complex biological processes in greater detail.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Semiconductors, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

high-throughput screeningphenotypic screeninglive cell analysiscell analysis platformdrug discoverylab-on-a-chipmulti-modal cell analysislife science toolsorgan-on-a-chipsingle-cell resolutionelectrophysiology platforme-physbiosensorshigh-content screeningcell-based assaysbiotech equipmentnon-optical cell analysisconsumable microplatescontract research organizationsCROs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CytoTronics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CytoTronics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 5, 2024
SeedApr 28, 2022

Key People

Founding team and executive leadership

Vince Wu

Co-founder CTO

Founding Team

Jeffrey Abbott

Co-Founder CEO

Founding Team

Michele Giovenelli

Chief Financial Officer

Executive Team

CytoTronics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 26, 2026

    Acquired high-throughput, high-density CMOS MEA technology assets from Axion BioSystems.

  • May 13, 2025

    Launched the Cardiac application for cell biology discovery.

CytoTronics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CytoTronics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CytoTronics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range12
Year Founded2020
Last FundingSep 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.